Vesugen
Also known as: Lys-Glu-Asp
Vesugen is a synthetic tripeptide, Lys-Glu-Asp (KED), from the Khavinson short-peptide 'bioregulator' series, positioned as a short-peptide analog of a bovine vascular-tissue polypeptide complex and claimed to be vasoprotective. Marketed on the Russian/Ukrainian grey market; not FDA-approved in the US; research-use only.
0 listings, ranked by trust score
Each row is a (vendor, peptide) pair. Click through for the listing detail, the vendor's full trust profile, and any COAs they've published.
No vendors carrying this peptide are indexed yet.
COAs for Vesugen
7 third-party tests across 2 vendors. Each card links to the full report.
For
Vesugen
by BioLongevity Labs· batch 46-3-46057
For
Vesugen
by Verified Peptides· batch 12-25-0220B
For
Vesugen
by BioLongevity Labs· batch 46-3-45954
For
Vesugen
by BioLongevity Labs· batch cmojb764d018zkirx8w2a46hx
For
Vesugen
by BioLongevity Labs· batch cmojb7d5r01aokirxjhjv4pxf
Purity not on file
For
Vesugen
by BioLongevity Labs· batch 46-3-45954
Purity not on file
For
Vesugen
by BioLongevity Labs· batch cmojb75xp018ykirxegzccad9